AstraZeneca: Acute Coronary Syndrome trials

The registry lists 36 Acute Coronary Syndrome studies with AstraZeneca as lead sponsor. 0 are open to participants now and 8 have results posted.

Phase 1 2Phase 3 5Phase 4 5No phase 24(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction StudyCompletedNCT02406677Phase 4Results posted
• Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin.TerminatedNCT02052635Phase 4Results posted
• Brilinta DaYu StudyCompletedNCT01870921Phase 4Results posted
• A Phase IV Study of the Onset and Maintenance of the Antiplatelet Effect of Ticagrelor Compared With Clopidogrel in Chinese Patients With ACSCompletedNCT01864005Phase 4Results posted
• Ad Hoc Percutaneous Coronary Intervention Study in Acute Coronary Syndrome PatientsCompletedNCT01603082Phase 4Results posted
• Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)CompletedNCT01294462Phase 3Results posted
• Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of AspirinCompletedNCT01225562Phase 3Results posted
• A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary SyndromeCompletedNCT00391872Phase 3Results posted
• ADHERE-S (NIS Brilique)CompletedNCT03444012
• Brilinta Clinical Experience InvestigationCompletedNCT03212287
• A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are AdministeredCompletedNCT03126695Phase 1
• Outcomes in UK ACS Patients Prescribed TicagrelorCompletedNCT03058601
• Phase 1, Single Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of MEDI5884CompletedNCT03001297Phase 1
• "Me and My Heart" StudyCompletedNCT02615704
• Evaluation on the Safety of Ticagrelor Among Chinese ACS PatientsCompletedNCT02430493
• An Observational Prospective Study to Understand the Usage Pattern of Ticagrelor With ACS (Acute Coronary Syndrome)CompletedNCT02408224
• Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China ExtensionCompletedNCT02305680
• RuSsian RegisTry of Acute CoronaRy SyndromE TreAtMent and Approach in Dual Antiplatelet TherapyCompletedNCT02288260
• Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical RegistryCompletedNCT02271022
• REalWorld Insights on the INitiation and Treatment Duration of ticagrEloR & Other Oral Antiplatelets (OAP) in Patients With Acute Coronary Syndrome (ACS) in Be/Lux.CompletedNCT02190123
• REal World Information on Cardiovascular Drug Management Patterns in Acute Coronary Syndrome paTientsCompletedNCT02001545
• A Retrospective Swedish Cohort Study on Health Outcomes, Life Expectancy, Resource Use and Costs in Patients With a History of Myocardial Infarction and Additional Risk Factors for AtherothrombosisCompletedNCT01984307
• Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary SyndromeCompletedNCT01952392
• Canadian Ticagrelor SurveyCompletedNCT01757483
• Sicilian Administrative Data Base Study in Acute Coronary Syndrome PatientsWithdrawnNCT01678339
• A Post Marketing Surveillance to Evaluate the Safety and Efficacy of BrilintaCompletedNCT01611272
• A NIS Registry of the Prospective Structured Care In Acute Coronary SyndromeCompletedNCT01490645
• Long-term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients in RussiaCompletedNCT01373957
• Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in AsiaCompletedNCT01361386
• Multicentre Retrospective Study to Understand Anti-thrombotic Treatment Patterns and Outcomes of Acute Coronary Syndrome (ACS) PatientsCompletedNCT01280630
• Extended Drug Utilization Study Among Patients Exposed to Ticagrelor, Clopidogrel and PrasugrelCompletedNCT01276275
• Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After DischargeCompletedNCT01171404
• Evaluation of Compliance With Management of Acute Coronary Syndrome on Discharge From Cardiac Intensive CareTerminatedNCT01105325
• An Epidemiological Study of Acute Coronary Syndromes in The Greek Population. The TARGET StudyCompletedNCT01061086
• Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary SyndromeCompletedNCT00296387Phase 3
• LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary SyndromesCompletedNCT00214630Phase 3